 | • レポートコード：MRC308GR03105 • 出版社/出版日：GlobalInfoResearch / 2023年8月 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（2-3営業日） • 産業分類：化学＆材料 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界のアプレピタントAPIの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のアプレピタントAPI市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– アプレピタントAPIの成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
アプレピタントAPI市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・純度≧99%、純度<99%
用途別セグメント
・注射剤、カプセル、乳剤、経口懸濁剤
主要な市場プレーヤー
・JUBILANT GENERICS LTD、PIRAMAL PHARMA LTD、MSN LABORATORIES PRIVATE LTD、HETERO DRUGS LTD、DR REDDYS LABORATORIES LTD、GLENMARK LIFE SCIENCES LTD、INKE SA、WISDOM PHARMACEUTICAL CO LTD、VIWIT PHARMACEUTICAL CO LTD、NAVINTA LLC、PHARMATHEN SA、SCINOPHARM TAIWAN LTD、AUROBINDO PHARMA LTD、WOCKHARDT BIO AG、SOLARA ACTIVE PHARMA SCIENCES LTD、OLON SPA、SHANDONG ANXIN PHARMACEUTICAL CO LTD、LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、アプレピタントAPI製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なアプレピタントAPIメーカーの企業概要、2019年～2022年までのアプレピタントAPIの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なアプレピタントAPIメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別アプレピタントAPIの販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのアプレピタントAPIの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのアプレピタントAPI市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびアプレピタントAPIの産業チェーンを掲載しています。
・第14、15章では、アプレピタントAPIの販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
- アプレピタントAPIの概要
- 種類別分析（2018年vs2022年vs2029年）：純度≧99%、純度<99%
- 用途別分析（2018年vs2022年vs2029年）：注射剤、カプセル、乳剤、経口懸濁剤
- 世界のアプレピタントAPI市場規模・予測
- 世界のアプレピタントAPI生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- JUBILANT GENERICS LTD、PIRAMAL PHARMA LTD、MSN LABORATORIES PRIVATE LTD、HETERO DRUGS LTD、DR REDDYS LABORATORIES LTD、GLENMARK LIFE SCIENCES LTD、INKE SA、WISDOM PHARMACEUTICAL CO LTD、VIWIT PHARMACEUTICAL CO LTD、NAVINTA LLC、PHARMATHEN SA、SCINOPHARM TAIWAN LTD、AUROBINDO PHARMA LTD、WOCKHARDT BIO AG、SOLARA ACTIVE PHARMA SCIENCES LTD、OLON SPA、SHANDONG ANXIN PHARMACEUTICAL CO LTD、LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：純度≧99%、純度<99%
・用途別分析2018年-2029年：注射剤、カプセル、乳剤、経口懸濁剤
・アプレピタントAPIの北米市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・アプレピタントAPIのヨーロッパ市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・アプレピタントAPIのアジア市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・アプレピタントAPIの南米市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・アプレピタントAPIの中東・アフリカ市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Aprepitant API
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Aprepitant API Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Purity≥99%
1.3.3 Purity<99%
1.4 Market Analysis by Application
1.4.1 Overview: Global Aprepitant API Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Injection
1.4.3 Capsule
1.4.4 Emulsion
1.4.5 Oral Suspension
1.5 Global Aprepitant API Market Size & Forecast
1.5.1 Global Aprepitant API Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Aprepitant API Sales Quantity (2018-2029)
1.5.3 Global Aprepitant API Average Price (2018-2029)
2 Manufacturers Profiles
2.1 JUBILANT GENERICS LTD
2.1.1 JUBILANT GENERICS LTD Details
2.1.2 JUBILANT GENERICS LTD Major Business
2.1.3 JUBILANT GENERICS LTD Aprepitant API Product and Services
2.1.4 JUBILANT GENERICS LTD Aprepitant API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 JUBILANT GENERICS LTD Recent Developments/Updates
2.2 PIRAMAL PHARMA LTD
2.2.1 PIRAMAL PHARMA LTD Details
2.2.2 PIRAMAL PHARMA LTD Major Business
2.2.3 PIRAMAL PHARMA LTD Aprepitant API Product and Services
2.2.4 PIRAMAL PHARMA LTD Aprepitant API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 PIRAMAL PHARMA LTD Recent Developments/Updates
2.3 MSN LABORATORIES PRIVATE LTD
2.3.1 MSN LABORATORIES PRIVATE LTD Details
2.3.2 MSN LABORATORIES PRIVATE LTD Major Business
2.3.3 MSN LABORATORIES PRIVATE LTD Aprepitant API Product and Services
2.3.4 MSN LABORATORIES PRIVATE LTD Aprepitant API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 MSN LABORATORIES PRIVATE LTD Recent Developments/Updates
2.4 HETERO DRUGS LTD
2.4.1 HETERO DRUGS LTD Details
2.4.2 HETERO DRUGS LTD Major Business
2.4.3 HETERO DRUGS LTD Aprepitant API Product and Services
2.4.4 HETERO DRUGS LTD Aprepitant API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 HETERO DRUGS LTD Recent Developments/Updates
2.5 DR REDDYS LABORATORIES LTD
2.5.1 DR REDDYS LABORATORIES LTD Details
2.5.2 DR REDDYS LABORATORIES LTD Major Business
2.5.3 DR REDDYS LABORATORIES LTD Aprepitant API Product and Services
2.5.4 DR REDDYS LABORATORIES LTD Aprepitant API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 DR REDDYS LABORATORIES LTD Recent Developments/Updates
2.6 GLENMARK LIFE SCIENCES LTD
2.6.1 GLENMARK LIFE SCIENCES LTD Details
2.6.2 GLENMARK LIFE SCIENCES LTD Major Business
2.6.3 GLENMARK LIFE SCIENCES LTD Aprepitant API Product and Services
2.6.4 GLENMARK LIFE SCIENCES LTD Aprepitant API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 GLENMARK LIFE SCIENCES LTD Recent Developments/Updates
2.7 INKE SA
2.7.1 INKE SA Details
2.7.2 INKE SA Major Business
2.7.3 INKE SA Aprepitant API Product and Services
2.7.4 INKE SA Aprepitant API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 INKE SA Recent Developments/Updates
2.8 WISDOM PHARMACEUTICAL CO LTD
2.8.1 WISDOM PHARMACEUTICAL CO LTD Details
2.8.2 WISDOM PHARMACEUTICAL CO LTD Major Business
2.8.3 WISDOM PHARMACEUTICAL CO LTD Aprepitant API Product and Services
2.8.4 WISDOM PHARMACEUTICAL CO LTD Aprepitant API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 WISDOM PHARMACEUTICAL CO LTD Recent Developments/Updates
2.9 VIWIT PHARMACEUTICAL CO LTD
2.9.1 VIWIT PHARMACEUTICAL CO LTD Details
2.9.2 VIWIT PHARMACEUTICAL CO LTD Major Business
2.9.3 VIWIT PHARMACEUTICAL CO LTD Aprepitant API Product and Services
2.9.4 VIWIT PHARMACEUTICAL CO LTD Aprepitant API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 VIWIT PHARMACEUTICAL CO LTD Recent Developments/Updates
2.10 NAVINTA LLC
2.10.1 NAVINTA LLC Details
2.10.2 NAVINTA LLC Major Business
2.10.3 NAVINTA LLC Aprepitant API Product and Services
2.10.4 NAVINTA LLC Aprepitant API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 NAVINTA LLC Recent Developments/Updates
2.11 PHARMATHEN SA
2.11.1 PHARMATHEN SA Details
2.11.2 PHARMATHEN SA Major Business
2.11.3 PHARMATHEN SA Aprepitant API Product and Services
2.11.4 PHARMATHEN SA Aprepitant API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 PHARMATHEN SA Recent Developments/Updates
2.12 SCINOPHARM TAIWAN LTD
2.12.1 SCINOPHARM TAIWAN LTD Details
2.12.2 SCINOPHARM TAIWAN LTD Major Business
2.12.3 SCINOPHARM TAIWAN LTD Aprepitant API Product and Services
2.12.4 SCINOPHARM TAIWAN LTD Aprepitant API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 SCINOPHARM TAIWAN LTD Recent Developments/Updates
2.13 AUROBINDO PHARMA LTD
2.13.1 AUROBINDO PHARMA LTD Details
2.13.2 AUROBINDO PHARMA LTD Major Business
2.13.3 AUROBINDO PHARMA LTD Aprepitant API Product and Services
2.13.4 AUROBINDO PHARMA LTD Aprepitant API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 AUROBINDO PHARMA LTD Recent Developments/Updates
2.14 WOCKHARDT BIO AG
2.14.1 WOCKHARDT BIO AG Details
2.14.2 WOCKHARDT BIO AG Major Business
2.14.3 WOCKHARDT BIO AG Aprepitant API Product and Services
2.14.4 WOCKHARDT BIO AG Aprepitant API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 WOCKHARDT BIO AG Recent Developments/Updates
2.15 SOLARA ACTIVE PHARMA SCIENCES LTD
2.15.1 SOLARA ACTIVE PHARMA SCIENCES LTD Details
2.15.2 SOLARA ACTIVE PHARMA SCIENCES LTD Major Business
2.15.3 SOLARA ACTIVE PHARMA SCIENCES LTD Aprepitant API Product and Services
2.15.4 SOLARA ACTIVE PHARMA SCIENCES LTD Aprepitant API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 SOLARA ACTIVE PHARMA SCIENCES LTD Recent Developments/Updates
2.16 OLON SPA
2.16.1 OLON SPA Details
2.16.2 OLON SPA Major Business
2.16.3 OLON SPA Aprepitant API Product and Services
2.16.4 OLON SPA Aprepitant API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 OLON SPA Recent Developments/Updates
2.17 SHANDONG ANXIN PHARMACEUTICAL CO LTD
2.17.1 SHANDONG ANXIN PHARMACEUTICAL CO LTD Details
2.17.2 SHANDONG ANXIN PHARMACEUTICAL CO LTD Major Business
2.17.3 SHANDONG ANXIN PHARMACEUTICAL CO LTD Aprepitant API Product and Services
2.17.4 SHANDONG ANXIN PHARMACEUTICAL CO LTD Aprepitant API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 SHANDONG ANXIN PHARMACEUTICAL CO LTD Recent Developments/Updates
2.18 LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD
2.18.1 LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD Details
2.18.2 LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD Major Business
2.18.3 LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD Aprepitant API Product and Services
2.18.4 LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD Aprepitant API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD Recent Developments/Updates
3 Competitive Environment: Aprepitant API by Manufacturer
3.1 Global Aprepitant API Sales Quantity by Manufacturer (2018-2023)
3.2 Global Aprepitant API Revenue by Manufacturer (2018-2023)
3.3 Global Aprepitant API Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Aprepitant API by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Aprepitant API Manufacturer Market Share in 2022
3.4.2 Top 6 Aprepitant API Manufacturer Market Share in 2022
3.5 Aprepitant API Market: Overall Company Footprint Analysis
3.5.1 Aprepitant API Market: Region Footprint
3.5.2 Aprepitant API Market: Company Product Type Footprint
3.5.3 Aprepitant API Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Aprepitant API Market Size by Region
4.1.1 Global Aprepitant API Sales Quantity by Region (2018-2029)
4.1.2 Global Aprepitant API Consumption Value by Region (2018-2029)
4.1.3 Global Aprepitant API Average Price by Region (2018-2029)
4.2 North America Aprepitant API Consumption Value (2018-2029)
4.3 Europe Aprepitant API Consumption Value (2018-2029)
4.4 Asia-Pacific Aprepitant API Consumption Value (2018-2029)
4.5 South America Aprepitant API Consumption Value (2018-2029)
4.6 Middle East and Africa Aprepitant API Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Aprepitant API Sales Quantity by Type (2018-2029)
5.2 Global Aprepitant API Consumption Value by Type (2018-2029)
5.3 Global Aprepitant API Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Aprepitant API Sales Quantity by Application (2018-2029)
6.2 Global Aprepitant API Consumption Value by Application (2018-2029)
6.3 Global Aprepitant API Average Price by Application (2018-2029)
7 North America
7.1 North America Aprepitant API Sales Quantity by Type (2018-2029)
7.2 North America Aprepitant API Sales Quantity by Application (2018-2029)
7.3 North America Aprepitant API Market Size by Country
7.3.1 North America Aprepitant API Sales Quantity by Country (2018-2029)
7.3.2 North America Aprepitant API Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Aprepitant API Sales Quantity by Type (2018-2029)
8.2 Europe Aprepitant API Sales Quantity by Application (2018-2029)
8.3 Europe Aprepitant API Market Size by Country
8.3.1 Europe Aprepitant API Sales Quantity by Country (2018-2029)
8.3.2 Europe Aprepitant API Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Aprepitant API Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Aprepitant API Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Aprepitant API Market Size by Region
9.3.1 Asia-Pacific Aprepitant API Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Aprepitant API Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Aprepitant API Sales Quantity by Type (2018-2029)
10.2 South America Aprepitant API Sales Quantity by Application (2018-2029)
10.3 South America Aprepitant API Market Size by Country
10.3.1 South America Aprepitant API Sales Quantity by Country (2018-2029)
10.3.2 South America Aprepitant API Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Aprepitant API Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Aprepitant API Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Aprepitant API Market Size by Country
11.3.1 Middle East & Africa Aprepitant API Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Aprepitant API Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Aprepitant API Market Drivers
12.2 Aprepitant API Market Restraints
12.3 Aprepitant API Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Aprepitant API and Key Manufacturers
13.2 Manufacturing Costs Percentage of Aprepitant API
13.3 Aprepitant API Production Process
13.4 Aprepitant API Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Aprepitant API Typical Distributors
14.3 Aprepitant API Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Aprepitant API Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Aprepitant API Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. JUBILANT GENERICS LTD Basic Information, Manufacturing Base and Competitors
Table 4. JUBILANT GENERICS LTD Major Business
Table 5. JUBILANT GENERICS LTD Aprepitant API Product and Services
Table 6. JUBILANT GENERICS LTD Aprepitant API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. JUBILANT GENERICS LTD Recent Developments/Updates
Table 8. PIRAMAL PHARMA LTD Basic Information, Manufacturing Base and Competitors
Table 9. PIRAMAL PHARMA LTD Major Business
Table 10. PIRAMAL PHARMA LTD Aprepitant API Product and Services
Table 11. PIRAMAL PHARMA LTD Aprepitant API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. PIRAMAL PHARMA LTD Recent Developments/Updates
Table 13. MSN LABORATORIES PRIVATE LTD Basic Information, Manufacturing Base and Competitors
Table 14. MSN LABORATORIES PRIVATE LTD Major Business
Table 15. MSN LABORATORIES PRIVATE LTD Aprepitant API Product and Services
Table 16. MSN LABORATORIES PRIVATE LTD Aprepitant API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. MSN LABORATORIES PRIVATE LTD Recent Developments/Updates
Table 18. HETERO DRUGS LTD Basic Information, Manufacturing Base and Competitors
Table 19. HETERO DRUGS LTD Major Business
Table 20. HETERO DRUGS LTD Aprepitant API Product and Services
Table 21. HETERO DRUGS LTD Aprepitant API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. HETERO DRUGS LTD Recent Developments/Updates
Table 23. DR REDDYS LABORATORIES LTD Basic Information, Manufacturing Base and Competitors
Table 24. DR REDDYS LABORATORIES LTD Major Business
Table 25. DR REDDYS LABORATORIES LTD Aprepitant API Product and Services
Table 26. DR REDDYS LABORATORIES LTD Aprepitant API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. DR REDDYS LABORATORIES LTD Recent Developments/Updates
Table 28. GLENMARK LIFE SCIENCES LTD Basic Information, Manufacturing Base and Competitors
Table 29. GLENMARK LIFE SCIENCES LTD Major Business
Table 30. GLENMARK LIFE SCIENCES LTD Aprepitant API Product and Services
Table 31. GLENMARK LIFE SCIENCES LTD Aprepitant API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. GLENMARK LIFE SCIENCES LTD Recent Developments/Updates
Table 33. INKE SA Basic Information, Manufacturing Base and Competitors
Table 34. INKE SA Major Business
Table 35. INKE SA Aprepitant API Product and Services
Table 36. INKE SA Aprepitant API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. INKE SA Recent Developments/Updates
Table 38. WISDOM PHARMACEUTICAL CO LTD Basic Information, Manufacturing Base and Competitors
Table 39. WISDOM PHARMACEUTICAL CO LTD Major Business
Table 40. WISDOM PHARMACEUTICAL CO LTD Aprepitant API Product and Services
Table 41. WISDOM PHARMACEUTICAL CO LTD Aprepitant API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. WISDOM PHARMACEUTICAL CO LTD Recent Developments/Updates
Table 43. VIWIT PHARMACEUTICAL CO LTD Basic Information, Manufacturing Base and Competitors
Table 44. VIWIT PHARMACEUTICAL CO LTD Major Business
Table 45. VIWIT PHARMACEUTICAL CO LTD Aprepitant API Product and Services
Table 46. VIWIT PHARMACEUTICAL CO LTD Aprepitant API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. VIWIT PHARMACEUTICAL CO LTD Recent Developments/Updates
Table 48. NAVINTA LLC Basic Information, Manufacturing Base and Competitors
Table 49. NAVINTA LLC Major Business
Table 50. NAVINTA LLC Aprepitant API Product and Services
Table 51. NAVINTA LLC Aprepitant API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. NAVINTA LLC Recent Developments/Updates
Table 53. PHARMATHEN SA Basic Information, Manufacturing Base and Competitors
Table 54. PHARMATHEN SA Major Business
Table 55. PHARMATHEN SA Aprepitant API Product and Services
Table 56. PHARMATHEN SA Aprepitant API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. PHARMATHEN SA Recent Developments/Updates
Table 58. SCINOPHARM TAIWAN LTD Basic Information, Manufacturing Base and Competitors
Table 59. SCINOPHARM TAIWAN LTD Major Business
Table 60. SCINOPHARM TAIWAN LTD Aprepitant API Product and Services
Table 61. SCINOPHARM TAIWAN LTD Aprepitant API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. SCINOPHARM TAIWAN LTD Recent Developments/Updates
Table 63. AUROBINDO PHARMA LTD Basic Information, Manufacturing Base and Competitors
Table 64. AUROBINDO PHARMA LTD Major Business
Table 65. AUROBINDO PHARMA LTD Aprepitant API Product and Services
Table 66. AUROBINDO PHARMA LTD Aprepitant API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. AUROBINDO PHARMA LTD Recent Developments/Updates
Table 68. WOCKHARDT BIO AG Basic Information, Manufacturing Base and Competitors
Table 69. WOCKHARDT BIO AG Major Business
Table 70. WOCKHARDT BIO AG Aprepitant API Product and Services
Table 71. WOCKHARDT BIO AG Aprepitant API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. WOCKHARDT BIO AG Recent Developments/Updates
Table 73. SOLARA ACTIVE PHARMA SCIENCES LTD Basic Information, Manufacturing Base and Competitors
Table 74. SOLARA ACTIVE PHARMA SCIENCES LTD Major Business
Table 75. SOLARA ACTIVE PHARMA SCIENCES LTD Aprepitant API Product and Services
Table 76. SOLARA ACTIVE PHARMA SCIENCES LTD Aprepitant API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. SOLARA ACTIVE PHARMA SCIENCES LTD Recent Developments/Updates
Table 78. OLON SPA Basic Information, Manufacturing Base and Competitors
Table 79. OLON SPA Major Business
Table 80. OLON SPA Aprepitant API Product and Services
Table 81. OLON SPA Aprepitant API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. OLON SPA Recent Developments/Updates
Table 83. SHANDONG ANXIN PHARMACEUTICAL CO LTD Basic Information, Manufacturing Base and Competitors
Table 84. SHANDONG ANXIN PHARMACEUTICAL CO LTD Major Business
Table 85. SHANDONG ANXIN PHARMACEUTICAL CO LTD Aprepitant API Product and Services
Table 86. SHANDONG ANXIN PHARMACEUTICAL CO LTD Aprepitant API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. SHANDONG ANXIN PHARMACEUTICAL CO LTD Recent Developments/Updates
Table 88. LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD Basic Information, Manufacturing Base and Competitors
Table 89. LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD Major Business
Table 90. LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD Aprepitant API Product and Services
Table 91. LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD Aprepitant API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD Recent Developments/Updates
Table 93. Global Aprepitant API Sales Quantity by Manufacturer (2018-2023) & (Tons)
Table 94. Global Aprepitant API Revenue by Manufacturer (2018-2023) & (USD Million)
Table 95. Global Aprepitant API Average Price by Manufacturer (2018-2023) & (US$/Ton)
Table 96. Market Position of Manufacturers in Aprepitant API, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 97. Head Office and Aprepitant API Production Site of Key Manufacturer
Table 98. Aprepitant API Market: Company Product Type Footprint
Table 99. Aprepitant API Market: Company Product Application Footprint
Table 100. Aprepitant API New Market Entrants and Barriers to Market Entry
Table 101. Aprepitant API Mergers, Acquisition, Agreements, and Collaborations
Table 102. Global Aprepitant API Sales Quantity by Region (2018-2023) & (Tons)
Table 103. Global Aprepitant API Sales Quantity by Region (2024-2029) & (Tons)
Table 104. Global Aprepitant API Consumption Value by Region (2018-2023) & (USD Million)
Table 105. Global Aprepitant API Consumption Value by Region (2024-2029) & (USD Million)
Table 106. Global Aprepitant API Average Price by Region (2018-2023) & (US$/Ton)
Table 107. Global Aprepitant API Average Price by Region (2024-2029) & (US$/Ton)
Table 108. Global Aprepitant API Sales Quantity by Type (2018-2023) & (Tons)
Table 109. Global Aprepitant API Sales Quantity by Type (2024-2029) & (Tons)
Table 110. Global Aprepitant API Consumption Value by Type (2018-2023) & (USD Million)
Table 111. Global Aprepitant API Consumption Value by Type (2024-2029) & (USD Million)
Table 112. Global Aprepitant API Average Price by Type (2018-2023) & (US$/Ton)
Table 113. Global Aprepitant API Average Price by Type (2024-2029) & (US$/Ton)
Table 114. Global Aprepitant API Sales Quantity by Application (2018-2023) & (Tons)
Table 115. Global Aprepitant API Sales Quantity by Application (2024-2029) & (Tons)
Table 116. Global Aprepitant API Consumption Value by Application (2018-2023) & (USD Million)
Table 117. Global Aprepitant API Consumption Value by Application (2024-2029) & (USD Million)
Table 118. Global Aprepitant API Average Price by Application (2018-2023) & (US$/Ton)
Table 119. Global Aprepitant API Average Price by Application (2024-2029) & (US$/Ton)
Table 120. North America Aprepitant API Sales Quantity by Type (2018-2023) & (Tons)
Table 121. North America Aprepitant API Sales Quantity by Type (2024-2029) & (Tons)
Table 122. North America Aprepitant API Sales Quantity by Application (2018-2023) & (Tons)
Table 123. North America Aprepitant API Sales Quantity by Application (2024-2029) & (Tons)
Table 124. North America Aprepitant API Sales Quantity by Country (2018-2023) & (Tons)
Table 125. North America Aprepitant API Sales Quantity by Country (2024-2029) & (Tons)
Table 126. North America Aprepitant API Consumption Value by Country (2018-2023) & (USD Million)
Table 127. North America Aprepitant API Consumption Value by Country (2024-2029) & (USD Million)
Table 128. Europe Aprepitant API Sales Quantity by Type (2018-2023) & (Tons)
Table 129. Europe Aprepitant API Sales Quantity by Type (2024-2029) & (Tons)
Table 130. Europe Aprepitant API Sales Quantity by Application (2018-2023) & (Tons)
Table 131. Europe Aprepitant API Sales Quantity by Application (2024-2029) & (Tons)
Table 132. Europe Aprepitant API Sales Quantity by Country (2018-2023) & (Tons)
Table 133. Europe Aprepitant API Sales Quantity by Country (2024-2029) & (Tons)
Table 134. Europe Aprepitant API Consumption Value by Country (2018-2023) & (USD Million)
Table 135. Europe Aprepitant API Consumption Value by Country (2024-2029) & (USD Million)
Table 136. Asia-Pacific Aprepitant API Sales Quantity by Type (2018-2023) & (Tons)
Table 137. Asia-Pacific Aprepitant API Sales Quantity by Type (2024-2029) & (Tons)
Table 138. Asia-Pacific Aprepitant API Sales Quantity by Application (2018-2023) & (Tons)
Table 139. Asia-Pacific Aprepitant API Sales Quantity by Application (2024-2029) & (Tons)
Table 140. Asia-Pacific Aprepitant API Sales Quantity by Region (2018-2023) & (Tons)
Table 141. Asia-Pacific Aprepitant API Sales Quantity by Region (2024-2029) & (Tons)
Table 142. Asia-Pacific Aprepitant API Consumption Value by Region (2018-2023) & (USD Million)
Table 143. Asia-Pacific Aprepitant API Consumption Value by Region (2024-2029) & (USD Million)
Table 144. South America Aprepitant API Sales Quantity by Type (2018-2023) & (Tons)
Table 145. South America Aprepitant API Sales Quantity by Type (2024-2029) & (Tons)
Table 146. South America Aprepitant API Sales Quantity by Application (2018-2023) & (Tons)
Table 147. South America Aprepitant API Sales Quantity by Application (2024-2029) & (Tons)
Table 148. South America Aprepitant API Sales Quantity by Country (2018-2023) & (Tons)
Table 149. South America Aprepitant API Sales Quantity by Country (2024-2029) & (Tons)
Table 150. South America Aprepitant API Consumption Value by Country (2018-2023) & (USD Million)
Table 151. South America Aprepitant API Consumption Value by Country (2024-2029) & (USD Million)
Table 152. Middle East & Africa Aprepitant API Sales Quantity by Type (2018-2023) & (Tons)
Table 153. Middle East & Africa Aprepitant API Sales Quantity by Type (2024-2029) & (Tons)
Table 154. Middle East & Africa Aprepitant API Sales Quantity by Application (2018-2023) & (Tons)
Table 155. Middle East & Africa Aprepitant API Sales Quantity by Application (2024-2029) & (Tons)
Table 156. Middle East & Africa Aprepitant API Sales Quantity by Region (2018-2023) & (Tons)
Table 157. Middle East & Africa Aprepitant API Sales Quantity by Region (2024-2029) & (Tons)
Table 158. Middle East & Africa Aprepitant API Consumption Value by Region (2018-2023) & (USD Million)
Table 159. Middle East & Africa Aprepitant API Consumption Value by Region (2024-2029) & (USD Million)
Table 160. Aprepitant API Raw Material
Table 161. Key Manufacturers of Aprepitant API Raw Materials
Table 162. Aprepitant API Typical Distributors
Table 163. Aprepitant API Typical Customers
List of Figures
Figure 1. Aprepitant API Picture
Figure 2. Global Aprepitant API Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Aprepitant API Consumption Value Market Share by Type in 2022
Figure 4. Purity≥99% Examples
Figure 5. Purity<99% Examples
Figure 6. Global Aprepitant API Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Aprepitant API Consumption Value Market Share by Application in 2022
Figure 8. Injection Examples
Figure 9. Capsule Examples
Figure 10. Emulsion Examples
Figure 11. Oral Suspension Examples
Figure 12. Global Aprepitant API Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Aprepitant API Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Aprepitant API Sales Quantity (2018-2029) & (Tons)
Figure 15. Global Aprepitant API Average Price (2018-2029) & (US$/Ton)
Figure 16. Global Aprepitant API Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Aprepitant API Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Aprepitant API by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Aprepitant API Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Aprepitant API Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Aprepitant API Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Aprepitant API Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Aprepitant API Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Aprepitant API Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Aprepitant API Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Aprepitant API Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Aprepitant API Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Aprepitant API Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Aprepitant API Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Aprepitant API Average Price by Type (2018-2029) & (US$/Ton)
Figure 31. Global Aprepitant API Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Aprepitant API Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Aprepitant API Average Price by Application (2018-2029) & (US$/Ton)
Figure 34. North America Aprepitant API Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Aprepitant API Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Aprepitant API Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Aprepitant API Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Aprepitant API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Aprepitant API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Aprepitant API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Aprepitant API Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Aprepitant API Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Aprepitant API Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Aprepitant API Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Aprepitant API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Aprepitant API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Aprepitant API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Aprepitant API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Aprepitant API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Aprepitant API Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Aprepitant API Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Aprepitant API Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Aprepitant API Consumption Value Market Share by Region (2018-2029)
Figure 54. China Aprepitant API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Aprepitant API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Aprepitant API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Aprepitant API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Aprepitant API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Aprepitant API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Aprepitant API Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Aprepitant API Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Aprepitant API Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Aprepitant API Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Aprepitant API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Aprepitant API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Aprepitant API Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Aprepitant API Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Aprepitant API Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Aprepitant API Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Aprepitant API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Aprepitant API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Aprepitant API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Aprepitant API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Aprepitant API Market Drivers
Figure 75. Aprepitant API Market Restraints
Figure 76. Aprepitant API Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Aprepitant API in 2022
Figure 79. Manufacturing Process Analysis of Aprepitant API
Figure 80. Aprepitant API Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source